Press Release

Venrock Raises $450 Million for Ninth Fund

March 8, 2021

Palo Alto – March 8, 2021 – Cooley advised Venrock on the closing of its ninth fund at $450 million. The fund will enable the venture capital firm to continue its mission to invest in early-stage technology and healthcare businesses that are taking novel approaches to solving important problems. Lawyers John Clendenin and Casey Schulte led the Cooley team advising Venrock.

Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies include Apple Computer, Athenahealth, Centocor, Check Point Software, Dollar Shave Club, DoubleClick, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel and Nest.

Cooley has advised Venrock on a range of matters, including its fund formations and investments, since 2003.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.